Viaskin Peanut: Completed Phase IIb enrollment

DBV completed enrollment of 221 patients ages 6-55 years in the double-blind, placebo-controlled, international Phase IIb VIPES trial evaluating 50, 100 and 250 µg Viaskin Peanut patches applied for 2...